|
(PQ #4) Single cell barcoding for studies of study clonal evolution in glioblasto
|
1R01CA190121-01
|
$332,000
|
VERHAAK, ROELAND
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQ6) Molecular Mechanisms of Dormancy in MYC-Driven Medulloblastoma
|
5R21CA180063-02
|
$205,701
|
PEI, YANXIN
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
(PQA1) The antipsychotic thioridazine protects against medulloblastoma (MB): volu
|
1R01CA185039-01
|
$386,223
|
JAN, LILY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQB5) Reconstruction of Evolutionary Networks using Cross-Sectional Genomic Data
|
1R01CA185486-01
|
$517,690
|
RABADAN, RAUL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw
|
1R01CA185137-01
|
$845,606
|
CHAREST, ALAIN
|
TUFTS MEDICAL CENTER
|
|
(PQC5) Detecting small clusters of tumor cells with a PTPmu probe
|
5R01CA179956-02
|
$598,485
|
BRADY-KALNAY, SUSANN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
(PQC5) MRI of magnetically labeled immune/stem cells for early tumor detection
|
1R21CA185163-01
|
$210,501
|
SHAPIRO, ERIK
|
MICHIGAN STATE UNIVERSITY
|
|
(PQD-5) Patient derived orthotopic xenograft models for drug response prediction
|
1R01CA185402-01
|
$324,033
|
LI, XIONAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQD3) Mechanisms of prolonged initial disease-free survival in glioblastoma
|
1R01CA184320-01
|
$669,147
|
SARKARIA, JANN
|
MAYO CLINIC ROCHESTER
|
|
(PQD4) MicroRNA Dysregulation in Field Effect is a Prerequisite for Tumorigenesis
|
1R21CA185504-01
|
$194,119
|
YANG, ZENG-JIE
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
00000000; D.GUY; SEVERABLE OPERATIONS FOR NCI-FREDERICK
|
261200800001E
|
$296,673,020
|
Heimbrook, David
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
18F-Fluorocholine to distinguish necrosis from recurrence in brain metastases
|
5R21CA170289-02
|
$355,854
|
BEAL, KATHRYN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
3D-Microtumor_GBM Xenoline Proband Modeling of Kinome-Directed Therapy
|
1R21CA185712-01
|
$203,585
|
WILLEY, CHRISTOPHER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN): A Phase II Clinica
|
5R44CA132257-04
|
$522,886
|
MORGAN, LEE
|
DEKK-TEC, INC.
|
|
5-hydroxymethylcytosine in human cancer
|
5R01CA160965-03
|
$338,142
|
PFEIFER, GERD
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
A causal role for asymmetric cell division defects in glioma initiation
|
5R01CA164746-03
|
$310,970
|
PETRITSCH, CLAUDIA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A Novel Approach to Treating Glioblastoma through Activation of the Liver X Recep
|
1F31CA186668-01
|
$34,393
|
VILLA, GENARO
|
LUDWIG INSTITUTE FOR CANCER RES LTD
|
|
A novel photopatterning-based paradigm for the study of 3D tumor infiltration
|
5F32CA174361-02
|
$49,214
|
RAPE, ANDREW
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
A NOVEL TARGETED DELIVERY SYSTEM FOR CANCER TREATMENT AND DIAGNOSIS
|
1R44CA183287-01A1
|
$222,359
|
MURASKI, JOHN
|
ENDURX PHARMACEUTICALS, INC.
|
|
A Phase I Study of CED of Liposomal-Irinotecan using imaging in High Grade Glioma
|
1R21CA186140-01
|
$324,935
|
BUTOWSKI, NICHOLAS
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A Predictive Prognostic Model for Glioblastoma Multiforme
|
5R01CA157553-03
|
$435,238
|
BUI, ALEX
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A Prospective Study of Social Competence in Pediatric Brain Tumor Survivors
|
5K07CA178100-02
|
$130,663
|
HOCKING, MATTHEW
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
A Wireless Laser Speckle and Fluorescence Imager for In vivo Brain Tumor Imaging
|
5R21CA175784-02
|
$170,891
|
PATHAK, ARVIND
|
JOHNS HOPKINS UNIVERSITY
|
|
A20 Promotes Glioma Stem Cell Mediated Tumorigenesis
|
5R01CA151522-05
|
$229,598
|
HJELMELAND, ANITA
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196 - 03152
|
$1,076,623
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-38S1
|
$74,997
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-38
|
$7,449,701
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Academic-Industrial Partnership to Develop Clinical Brain Cancer Imaging
|
5R01CA166171-02
|
$449,060
|
ZHOU, JINYUAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Adoptive Transfer of AlloCTL for Immunotherapy of Recurrent Gliomas
|
3R01CA125244-05S1
|
$14,664
|
KRUSE, CAROL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Adoptive Transfer of AlloCTL for Immunotherapy of Recurrent Gliomas
|
5R01CA125244-05
|
$212,019
|
KRUSE, CAROL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Adult Brain Tumor Consortium (ABTC)
|
2UM1CA137443-06
|
$1,999,278
|
GROSSMAN, STUART
|
JOHNS HOPKINS UNIVERSITY
|
|
Advanced MRI methods for detecting pseudo-progression of glioblastomas
|
5R21CA170284-02
|
$320,232
|
POPTANI, HARISH
|
UNIVERSITY OF PENNSYLVANIA
|
|
Akt-EphA2 Crosstalk in Glioma Invasion
|
5R01CA152371-05
|
$316,002
|
WANG, BINGCHENG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
1U10CA180821-01
|
$10,540,919
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S1
|
$228,063
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S2
|
$264,661
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S3
|
$16,838
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alternative Mechanisms to Inactivate p53 During Oncogenesis
|
3R01CA156706-05S1
|
$61,951
|
SHEN, ZHIYUAN
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Alternative Mechanisms to Inactivate p53 During Oncogenesis
|
5R01CA156706-05
|
$320,027
|
SHEN, ZHIYUAN
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
An innovative in situ cell reprogramming technology for cancer treatment
|
1R41CA183103-01
|
$225,000
|
JIANG, FENG
|
QURGEN, INC.
|
|
An Investigation of Radial Glia as the Source of Ependymoma Stem Cells
|
5R01CA129541-08
|
$312,849
|
GILBERTSON, RICHARD
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Analysis of active and inactive EGFR conformations
|
5R01CA112552-09
|
$227,517
|
FERGUSON, KATHRYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Analysis of genetic changes associated with astrocytomagenesis
|
ZIA BC 011590
|
$293,310
|
Van Dyke, Terry
|
CCR (NCI)
|
|
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer
|
5R01CA169345-02
|
$312,983
|
WALDMAN, TODD
|
GEORGETOWN UNIVERSITY
|
|
Angiogenesis-targeting therapy for glioblastoma
|
5R01CA129371-07
|
$361,430
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Annexin A2 as a Novel Enhancer of Tumor-Associated Antigen Processing
|
5F30CA167912-02
|
$47,676
|
ANDERSEN, BRIAN
|
UNIVERSITY OF MINNESOTA
|
|
Anticancer Drug Pharmacology in Very Young Children
|
5R01CA154619-03
|
$420,471
|
STEWART, CLINTON
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Apical-basal polarity signaling in glioblastoma
|
3R01CA149258-05S1
|
$67,717
|
GHOSH, SOURAV
|
UNIVERSITY OF ARIZONA
|
|
Apical-basal polarity signaling in glioblastoma
|
5R01CA149258-05
|
$301,151
|
GHOSH, SOURAV
|
UNIVERSITY OF ARIZONA
|
|
Apoptosis driven by elastase inhibitor: new approach to detection and study.
|
5R21CA178365-02
|
$165,089
|
DIDENKO, VLADIMIR
|
BAYLOR COLLEGE OF MEDICINE
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|